PYXS
Pyxis Oncology, Inc.
+0.02 (+0.60%)3.36USD163K成交股數280M市值–本益比(近四季)20.2股價營收比–營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | 2.8M | – | – | – | – | 16.1M | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | 475K | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | 15.7M | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | 97.1% | – | – | – |
| 研發費用 | 16.1M | 20.0M | 17.8M | 17.1M | 17.0M | 14.0M | 17.7M | 14.0M | 13.0M | 14.7M | 11.4M | 11.9M |
| 銷售管理費用 | 9.9M | 4.4M | 5.7M | 5.4M | 5.9M | 5.1M | 6.0M | 6.1M | 8.2M | 10.7M | 6.7M | 9.1M |
| 營業利益 | −26.0M+13% | −24.4M-39% | −23.5M-1% | −19.8M-1% | −22.9M+309% | −40.1M+58% | −23.8M+31% | −20.0M-4% | −5.6M | −25.4M | −18.1M | −21.0M |
| 營業利益率 | – | – | – | -700.4% | – | – | – | – | -34.7% | – | – | – |
| 稅後淨利 | −25.3M+20% | −23.3M-35% | −22.0M+4% | −18.4M+6% | −21.2M+550% | −35.6M+54% | −21.2M+33% | −17.3M-10% | −3.3M | −23.0M | −15.9M | −19.2M |
| 淨利率 | – | – | – | -650.9% | – | – | – | – | -20.2% | – | – | – |
| 稀釋 EPS | -0.40+14% | -0.37-40% | -0.350% | -0.30+3% | -0.35+483% | -0.62+11% | -0.35-15% | -0.29-46% | -0.06 | -0.56 | -0.41 | -0.54 |
| 稀釋股數 | 64.0M | 63.5M | 62.6M | 61.9M | 61.0M | 58.4M | 60.7M | 60.5M | 51.3M | 41.3M | 38.4M | 35.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 18.9M | 5.8M | 8.9M | 10.7M | 12.8M | 19.5M | 12.1M | 25.1M | 28.0M | 14.7M | 25.9M | 53.1M |
| 應收帳款 | – | – | – | 3.0M | – | – | – | – | 8.0M | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 54.9M | 64.3M | 106M | 123M | 136M | 157M | 195M | 208M | 220M | 187M | 175M | 183M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 43.5M | 33.0M | 36.8M | 35.6M | 32.8M | 36.4M | 41.6M | 38.6M | 36.1M | 48.7M | 30.0M | 30.6M |
| 股東權益 | 11.4M | 31.3M | 68.8M | 87.6M | 103M | 121M | 154M | 170M | 184M | 138M | 145M | 152M |
| 負債比 | 79.2% | 51.4% | 34.9% | 28.9% | 24.1% | 23.2% | 21.3% | 18.5% | 16.4% | 26.1% | 17.1% | 16.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −26.0M | – | – | −22.5M+9% | – | – | – | −20.7M | – | – | −26.8M |
| 資本支出 | – | – | – | – | – | – | – | – | 237K | – | – | 4.4M |
| 自由現金流 | – | – | – | – | – | – | – | – | −20.9M | – | – | −31.2M |
| 折舊攤銷 | – | 459K | – | – | 552K | – | – | – | 1.1M | – | – | 190K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -129.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 13.9M
| Sale Of Royalty Rights | 11.0M | 79.7% | +38.0% |
|---|---|---|---|
| Milestone Revenue | 2.8M | 20.3% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 13.9M | -14.2% | −79.6M | -574.5% | -1.28 | −63.5M |
| FY2024 | 16.1M | – | −77.3M | -478.9% | -1.32 | −57.9M |
| FY2023 | – | – | −73.8M | –% | -1.85 | −77.4M |
| FY2022 | – | – | −121M | –% | -3.65 | −95.7M |
| FY2021 | – | – | −76.0M | –% | -8.95 | −35.9M |
| FY2020 | – | – | −12.8M | –% | -12.45 | −11.6M |